Pfizer jabs delivers less antibodies against Delta variation of Covid: Lancet study Kumar Jeetendra | June 4, 2021 People fully vaccinated with the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal. The study also shows that levels of these antibodies that are able to recognise …
Glenmark Pharma gets last gesture from USFDA for Theophylline ER tablets Kumar Jeetendra | June 4, 2021 Glenmark Pharma on Friday said it has received final approval from the US health regulator for Theophylline extended-release (ER) tablets. Theophylline extended-release tablets are used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. In a regulatory filing Glenmark Pharmaceuticals said it has …
Moderna looks for full FDA endorsement for its COVID-19 vaccine Kumar Jeetendra | June 1, 2021 American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults. Moderna announced on Tuesday it has begun a “rolling submission” to the Food and Drug Administration of data from its studies of the two-dose vaccine. Moderna’s vaccine already has been …
Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients Kumar Jeetendra | May 28, 2021 Bajaj Healthcare on Friday launched Posaconazole API, used in treating Mucormycosis (black fungus) infection in COVID-19 patients. The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing. Bajaj Healthcare …
BDR Pharma launches the first generic RUCAPARIB to treat advanced ovarian and prostate cancers in India Kumar Jeetendra | May 27, 2021 Mumbai, 27 May 2021: BDR Pharmaceutical launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers today. BDPARIB is the first affordable generic in the India available in the form of a tablet, with the cost of therapy less expensive than any existing drugs in the market. RUCAPARIB is an oral, small-molecule inhibitor of poly …
Glenmark Pharma gets USFDA gesture for Icatibant Injection Kumar Jeetendra | May 25, 2021 Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE). Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling. The approved product is a generic version of Firazyr Injection …
Bal Pharma dispatches antiviral drug Favipiravir at Rs 85/tablet Kumar Jeetendra | May 24, 2021 Drug maker Bal Pharma on Monday said it has launched antiviral drug Favipiravir in the domestic market under the brand name BALflu for the treatment of COVID-19. The Bengaluru-based company said its formulation would be available in tablet form with 400 mg strength. Favipiravir is being used for patients with mild to moderate COVID-19 infection as it …
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India Kumar Jeetendra | May 24, 2021 Mumbai, 24 May 2021: Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000 patients as …
Sun Pharma reviews 50,868 bottles of diabetes drug in US Kumar Jeetendra | May 22, 2021 New Delhi, May 21 (PTI) Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA). The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to …
Natco Pharma gets USFDA gesture for generic cancer trearment drug Kumar Jeetendra | May 22, 2021 New Delhi, May 22 (PTI) Natco Pharma on Saturday said it has received approval from the US health regulator for generic Lenalidomide capsules indicated for treatment of adults with multiple myeloma, mantle cell lymphoma and myelodysplastic syndromes. The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new …
Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test Kumar Jeetendra | May 20, 2021 Mumbai, India; May 20 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla’s third offering in the Covid-19 testing segment. Cipla already has partnerships …
Optimus Pharma gets DCGI gesture to lead Phase-3 preliminary of COVID-19 antiviral drug Kumar Jeetendra | May 19, 2021 The orally administered drug is being tested for treating mild and moderate infection Optimus Pharma has obtained the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection. In accordance with the clinical trial protocols approved, a …
